- Home
- RVPH vs MGRX Comparison
RVPH vs MGRX Comparison
Compare RVPH & MGRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- MGRX
- Stock Information
- Founded
- RVPH 2006
- MGRX 2021
- Country
- RVPH United States
- MGRX United States
- Employees
- RVPH N/A
- MGRX N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- MGRX Computer Software: Prepackaged Software
- Sector
- RVPH Health Care
- MGRX Technology
- Exchange
- RVPH Nasdaq
- MGRX Nasdaq
- Market Cap
- RVPH 18.1M
- MGRX 20.6M
- IPO Year
- RVPH N/A
- MGRX 2023
- Fundamental
- Price
- RVPH $0.54
- MGRX $1.20
- Analyst Decision
- RVPH Strong Buy
- MGRX
- Analyst Count
- RVPH 6
- MGRX 0
- Target Price
- RVPH $3.33
- MGRX N/A
- AVG Volume (30 Days)
- RVPH 7.9M
- MGRX 3.7M
- Earning Date
- RVPH 11-13-2025
- MGRX 11-14-2025
- Dividend Yield
- RVPH N/A
- MGRX N/A
- EPS Growth
- RVPH N/A
- MGRX N/A
- EPS
- RVPH N/A
- MGRX N/A
- Revenue
- RVPH N/A
- MGRX $516,030.00
- Revenue This Year
- RVPH N/A
- MGRX N/A
- Revenue Next Year
- RVPH N/A
- MGRX N/A
- P/E Ratio
- RVPH N/A
- MGRX N/A
- Revenue Growth
- RVPH N/A
- MGRX N/A
- 52 Week Low
- RVPH $0.25
- MGRX $0.99
- 52 Week High
- RVPH $4.28
- MGRX $6.15
- Technical
- Relative Strength Index (RSI)
- RVPH 48.43
- MGRX 29.83
- Support Level
- RVPH $0.45
- MGRX $1.64
- Resistance Level
- RVPH $0.59
- MGRX $2.41
- Average True Range (ATR)
- RVPH 0.06
- MGRX 0.31
- MACD
- RVPH -0.01
- MGRX -0.08
- Stochastic Oscillator
- RVPH 41.93
- MGRX 9.44
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.
About MGRX Mangoceuticals Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.